Bank Of New York Mellon Corp Eagle Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$25.06 - $34.09 $2.84 Million - $3.87 Million	113,413 New	113,413 $3.22 Billion
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $2.99 Million - $4.76 Million	119,740 New	119,740 $3.5 Million
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $100,211 - $178,726	3,793 Added 3.7%	106,317 $2.81 Million
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $550,614 - $685,265	-13,345 Reduced 11.52%	102,524 $4.56 Million
Q1 2022 May 11, 2022	SELL	$44.58 - $52.6 $391,412 - $461,828	-8,780 Reduced 7.04%	115,869 $5.74 Million
Q4 2021 Feb 11, 2022	SELL	$45.82 - $56.9 $42,291 - $52,518	-923 Reduced 0.74%	124,649 $6.35 Million
Q3 2021 Nov 12, 2021	BUY	$43.79 - $55.78 $458,787 - $584,407	10,477 Added 9.1%	125,572 $7.01 Million
Q2 2021 Aug 11, 2021	SELL	$36.86 - $44.5 $182,973 - $220,898	-4,964 Reduced 4.13%	115,095 $4.93 Million
Q1 2021 May 13, 2021	SELL	$40.32 - $50.97 $332,357 - $420,145	-8,243 Reduced 6.42%	120,059 $5.01 Million
Q4 2020 Feb 09, 2021	SELL	$41.72 - $51.34 $59,200 - $72,851	-1,419 Reduced 1.09%	128,302 $5.98 Million
Q3 2020 Nov 12, 2020	BUY	$37.02 - $51.28 $609,571 - $844,376	16,466 Added 14.54%	129,721 $5.51 Million
Q2 2020 Aug 12, 2020	BUY	$43.24 - $55.02 $148,918 - $189,488	3,444 Added 3.14%	113,255 $5.43 Million
Q1 2020 May 06, 2020	SELL	$34.37 - $60.07 $244,989 - $428,178	-7,128 Reduced 6.1%	109,811 $5.05 Million
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $348,462 - $412,548	-6,415 Reduced 5.2%	116,939 $7.03 Million
Q3 2019 Nov 07, 2019	SELL	$53.25 - $59.98 $285,420 - $321,492	-5,360 Reduced 4.16%	123,354 $6.98 Million
Q2 2019 Aug 12, 2019	SELL	$46.61 - $58.45 $198,605 - $249,055	-4,261 Reduced 3.2%	128,714 $7.17 Million
Q1 2019 May 14, 2019	SELL	$38.66 - $51.82 $162,719 - $218,110	-4,209 Reduced 3.07%	132,975 $6.72 Million
Q4 2018 Feb 11, 2019	SELL	$36.72 - $67.73 $1.48 Million - $2.74 Million	-40,435 Reduced 22.77%	137,184 $5.53 Million
Q3 2018 Nov 09, 2018	BUY	$66.65 - $83.86 $1.59 Million - $2 Million	23,903 Added 15.55%	177,619 $0
Q2 2018 Aug 06, 2018	BUY	$51.25 - $76.62 $323,387 - $483,472	6,310 Added 4.28%	153,716 $11.6 Million
Q1 2018 May 15, 2018	SELL	$52.16 - $66.86 $390,104 - $500,045	-7,479 Reduced 4.83%	147,406 $7.77 Million
Q4 2017 Feb 09, 2018	BUY	$49.6 - $60.87 $7.68 Million - $9.43 Million	154,885	154,885 $8.28 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account